Tivic Health Systems (NASDAQ: TIVC) shares new January 2026 investor deck

Rhea-AI Filing Summary

Tivic Health Systems, Inc. filed a current report to note that it has made a corporate presentation available to investors on its website as of January 20, 2026. The presentation, dated January 2026, is included as Exhibit 99.1 and is provided under Regulation FD, which is intended to ensure fair public disclosure of material information.

The company explains that this investor presentation and the related disclosure are being "furnished" rather than "filed," meaning they are not subject to certain legal liabilities under the Securities Exchange Act and will not be automatically incorporated into other securities filings unless specifically referenced. The report also includes standard cautionary language about forward-looking statements, emphasizing that actual results may differ materially due to various risks and uncertainties described in Tivic Health’s filings with the SEC.

false 0001787740 0001787740 2026-01-20 2026-01-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 20, 2026

Tivic Health Systems, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware		001-41052		81-4016391
(State or Other Jurisdiction		(Commission File Number)		(IRS Employer
of Incorporation)				Identification No.)
47685 Lakeview Blvd.
Fremont, California				94538
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 888 276-6888

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		TIVC		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On January 20, 2026, Tivic Health Systems, Inc. (the “Company”) made available to investors a presentation on its website at https://tivichealth.com. The presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K (the “Report”).

The information set forth under Item 7.01 of this Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing, except as expressly set forth by specific reference in such a filing. This Report will not be deemed an admission as to the materiality of any information in this Report that is required to be disclosed solely by Regulation FD.

Forward-Looking Statements

This Report, including Exhibit 99.1 attached hereto, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein, the terms “anticipates,” “expects,” “estimates,” “believes,” “will” and similar expressions, as they relate to us or our management, are intended to identify such forward-looking statements.

Forward-looking statements in this Report, including Exhibit 99.1 attached hereto, or hereafter, including in other publicly available documents filed with the Securities and Exchange Commission (the “Commission”), reports to the stockholders of the Company and other publicly available statements issued or released by us involve known and unknown risks, uncertainties and other factors which could cause our actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. Such future results are based upon management’s best estimates based upon current conditions and the most recent results of operations. These risks include, but are not limited to, the risks set forth herein and in such other documents filed with the Commission, each of which could adversely affect our business and the accuracy of the forward-looking statements contained herein. Our actual results, performance or achievements may differ materially from those expressed or implied by such forward-looking statements.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Corporate Presentation, dated January 2026.
104		Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).

11

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			TIVIC HEALTH SYSTEMS, INC.
Date:	January 20, 2026	By:	/s/ Jennifer Ernst
			Name: Jennifer Ernst Title: Chief Executive Officer

12

FAQ

What did Tivic Health Systems (TIVC) disclose in this 8-K filing?

Tivic Health Systems reported that it made an investor presentation available on its website on January 20, 2026. The presentation, dated January 2026, is attached as Exhibit 99.1 and is provided under Regulation FD to support broad, equal access to information for investors.

Where can investors access Tivic Health Systems' January 2026 corporate presentation?

The company states that the investor presentation is available on its website at https://tivichealth.com, and the same materials are attached to the report as Exhibit 99.1.

Is the Tivic Health Systems investor presentation considered filed or furnished to the SEC?

The company specifies that the information in Item 7.01 and Exhibit 99.1 is being furnished, not filed, under the Securities Exchange Act of 1934. As a result, it is not subject to the liabilities of Section 18 and is not automatically incorporated into other SEC filings unless specifically referenced.

Does this Tivic Health Systems 8-K include forward-looking statements?

Yes. The report notes that it, including Exhibit 99.1, contains forward-looking statements identified by terms such as “anticipates,” “expects,” “estimates,” “believes,” and “will.” It cautions that actual results may differ materially due to risks and uncertainties described in Tivic Health’s SEC filings.

What exhibits are attached to this Tivic Health Systems (TIVC) 8-K?

The filing lists Exhibit 99.1, a corporate presentation dated January 2026, and Exhibit 104, the cover page interactive data file formatted in Inline XBRL.

Who signed this Tivic Health Systems 8-K report?

The report was signed on behalf of Tivic Health Systems, Inc. by Jennifer Ernst, who is identified as the company’s Chief Executive Officer.